ATE339411T1 - 1,2,4 trioxolan-antimalariamittel - Google Patents
1,2,4 trioxolan-antimalariamittelInfo
- Publication number
- ATE339411T1 ATE339411T1 AT02763208T AT02763208T ATE339411T1 AT E339411 T1 ATE339411 T1 AT E339411T1 AT 02763208 T AT02763208 T AT 02763208T AT 02763208 T AT02763208 T AT 02763208T AT E339411 T1 ATE339411 T1 AT E339411T1
- Authority
- AT
- Austria
- Prior art keywords
- trioxolane
- group
- ring
- antimalariatic
- trioxolan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07D323/02—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/886,666 US6486199B1 (en) | 2001-06-21 | 2001-06-21 | Spiro and dispiro 1,2,4-trioxolane antimalarials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE339411T1 true ATE339411T1 (de) | 2006-10-15 |
Family
ID=25389491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02763208T ATE339411T1 (de) | 2001-06-21 | 2002-06-21 | 1,2,4 trioxolan-antimalariamittel |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6486199B1 (de) |
| EP (1) | EP1414813B1 (de) |
| JP (1) | JP4303585B2 (de) |
| KR (1) | KR100759144B1 (de) |
| CN (1) | CN1545508B (de) |
| AT (1) | ATE339411T1 (de) |
| AU (1) | AU2002327183B2 (de) |
| BR (1) | BRPI0210549B8 (de) |
| CA (1) | CA2451006C (de) |
| CY (1) | CY1106214T1 (de) |
| DE (1) | DE60214733T8 (de) |
| DK (1) | DK1414813T3 (de) |
| ES (1) | ES2271323T3 (de) |
| HU (1) | HUP0400246A3 (de) |
| IL (1) | IL159474A0 (de) |
| MX (1) | MXPA03011915A (de) |
| NO (1) | NO20035721L (de) |
| PL (1) | PL226418B1 (de) |
| PT (1) | PT1414813E (de) |
| RU (1) | RU2271357C2 (de) |
| SI (1) | SI1414813T1 (de) |
| UA (1) | UA78709C2 (de) |
| WO (1) | WO2003000676A1 (de) |
| YU (1) | YU100703A (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE536887T1 (de) * | 2002-06-06 | 2011-12-15 | Univ Washington | Kovalente konjugate zwischen mit artemisinin verwandten endoperoxiden und eisentragenden proteinen und anwendungsverfahren |
| US20080125441A1 (en) * | 2002-06-21 | 2008-05-29 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6906205B2 (en) * | 2002-06-21 | 2005-06-14 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6825230B2 (en) * | 2002-06-21 | 2004-11-30 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trixolane antimalarials |
| US7371778B2 (en) * | 2002-06-21 | 2008-05-13 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| FR2862304A1 (fr) * | 2003-11-14 | 2005-05-20 | Centre Nat Rech Scient | Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
| US20080275112A1 (en) * | 2004-07-23 | 2008-11-06 | Schreiner Peter R | Invention Concerning Aminoadamantane Compounds |
| US20060040761A1 (en) * | 2004-08-23 | 2006-02-23 | Sam-Kyu Shin | Scale mark mat for putting practice |
| US8067620B2 (en) * | 2005-05-04 | 2011-11-29 | Medicines For Malaria Venture Mmv | Dispiro 1,2,4-trioxolane antimalarials |
| PL1898901T3 (pl) | 2005-05-18 | 2017-07-31 | Sun Pharmaceutical Industries Limited | Stabilne postacie dawkowania spiro i dispiro 1, 2, 4-trioksolanowych związków przeciwmalarycznych |
| WO2007036947A1 (en) * | 2005-09-30 | 2007-04-05 | Ipca Laboratories Limited | Delayed release anti-malarial composition |
| ATE464301T1 (de) | 2005-10-04 | 2010-04-15 | Director General Defence Res & | Aus gomphostemma niveum isolierte verbindung gegen malaria |
| WO2007112451A2 (en) * | 2006-03-28 | 2007-10-04 | University Of Washington | Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| JP2009533368A (ja) | 2006-04-11 | 2009-09-17 | ノバルティス アクチエンゲゼルシャフト | 有機化合物 |
| AP2525A (en) * | 2006-05-17 | 2012-12-05 | Ranbaxy Lab Ltd | Antimarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative |
| SI2029569T1 (sl) * | 2006-05-24 | 2013-03-29 | Ranbaxy Laboratories Limited | Postopek za pripravo dispiro-1,2,4-trioksolanskega protimalarijskega sredstva (OZ277 soli) |
| FR2902100A1 (fr) * | 2006-06-13 | 2007-12-14 | Sanofi Aventis Sa | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
| GB0619333D0 (en) * | 2006-09-30 | 2006-11-08 | Univ Liverpool | Dispiro tetraoxane compounds |
| WO2008046109A2 (en) * | 2006-10-13 | 2008-04-17 | University Of Washington | Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer |
| FR2924343A1 (fr) * | 2007-12-04 | 2009-06-05 | Palumed Sa | Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique. |
| WO2010001824A1 (ja) * | 2008-07-01 | 2010-01-07 | 国立大学法人 岡山大学 | 新規抗住血吸虫剤 |
| US8618096B2 (en) | 2008-07-21 | 2013-12-31 | The Regents Of The University Of California | Prodrug compositions and methods for using the same in treating cancer and malaria |
| MX2014000463A (es) | 2011-07-14 | 2014-07-09 | Ranbaxy Lab Ltd | Formas de dosificacion estables de aterolane y piperaquina. |
| WO2015123595A1 (en) | 2014-02-14 | 2015-08-20 | The Regents Of The University Of California | Cyclic peroxides as prodrugs for selective delivery of agents |
| AU2015370911B2 (en) | 2014-12-23 | 2020-07-09 | Bergenbio Asa | Inhibitors of Akt kinase |
| RU2601315C1 (ru) * | 2015-06-10 | 2016-11-10 | Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук | Способ получения пентаоксаспироалканов |
| WO2019005977A1 (en) * | 2017-06-27 | 2019-01-03 | The Regents Of The University Of California | TRIOXOLANE AGENTS |
| CN108424371B (zh) * | 2018-01-19 | 2021-07-16 | 北京理工大学 | 2-(4-氨基环己基)-乙酸乙酯的制备方法 |
| US20210386814A1 (en) * | 2020-05-20 | 2021-12-16 | Amanuel Tesfazion | Methods and compound for the treatment of malaria |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3621062A (en) | 1966-10-25 | 1971-11-16 | Sterling Drug Inc | 2-(8-cyclohexyloctanoyl or 7-cyclohexylheptanoyl)-1-naphthol |
| US3673222A (en) | 1969-11-26 | 1972-06-27 | Sydney Archer | 2-(8-cyclohexyloctyl or 7-cyclohexylheptyl)-1,4-naphthoquinone and process for preparation and use thereof |
| US3682991A (en) | 1970-10-19 | 1972-08-08 | Sterling Drug Inc | 3,3,5-trimethylcyclohexyl-alkyl-carboxylic acids |
| US4916204A (en) | 1987-07-31 | 1990-04-10 | Massachusetts Institute Of Technology | Pure polyanhydride from dicarboxylic acid and coupling agent |
| US4816478A (en) | 1987-08-24 | 1989-03-28 | Thornfeldt Carl R | Treatment of acquired immunodeficiency syndrome |
| US5053342A (en) | 1987-12-24 | 1991-10-01 | Litmus Concepts, Inc. | Fecal occult blood test reagents |
| US5559145A (en) | 1988-06-01 | 1996-09-24 | Oxaco S.A. | 1,2,4-trioxane derivatives |
| US5270344A (en) | 1988-06-24 | 1993-12-14 | Stephen Herman | Method of treating a systemic disorder using trioxolane and diperoxide compounds |
| JP2867529B2 (ja) | 1990-01-22 | 1999-03-08 | 三菱電機株式会社 | 投写型表示装置 |
| US5216175A (en) | 1990-03-23 | 1993-06-01 | Sri International | Antimalarial analogs of artemisinin |
| US5219880A (en) | 1991-03-29 | 1993-06-15 | Dermatologic Research Corporation | Treatment of viral tumors and hemorrhoids with artemisinin and derivatives |
| US5510356A (en) | 1991-10-03 | 1996-04-23 | University Of Nebraska Board Of Regents | Bisquinolines and processes for their production and use to treat malaria |
| US5171676A (en) | 1991-10-31 | 1992-12-15 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of introducing hydroxyl groups into artemisinin and its derivatives |
| US5430148A (en) | 1992-03-31 | 1995-07-04 | Agouron Pharmaceuticals, Inc. | Antiproliferative quinazolines |
| ATE152630T1 (de) | 1992-07-28 | 1997-05-15 | Procter & Gamble | Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält |
| US5721209A (en) | 1995-02-03 | 1998-02-24 | The Regents Of The University Of California | Iron chelator and inhibitor of iron-mediated oxidant injury |
| US5780675A (en) | 1995-04-28 | 1998-07-14 | The University Of New Mexico | Deoxygossylic compounds |
| US5578637A (en) | 1995-05-03 | 1996-11-26 | University Of Washington | Methods of inhibition or killing cancer cells using an endoperoxide |
| US5817692A (en) | 1995-11-22 | 1998-10-06 | The Johns Hopkins University | Endoperoxides useful as antiparasitic agents |
| US5672624A (en) | 1995-11-22 | 1997-09-30 | The Johns Hopkins University | Endoperoxides useful as antiparasitic agents |
| US5932591A (en) | 1996-12-02 | 1999-08-03 | Johns Hopkins University | C3 substituted trioxanes useful as antiparasitic drugs |
-
2001
- 2001-06-21 US US09/886,666 patent/US6486199B1/en not_active Expired - Lifetime
-
2002
- 2002-06-21 PL PL367158A patent/PL226418B1/pl unknown
- 2002-06-21 YU YU100703A patent/YU100703A/sh unknown
- 2002-06-21 MX MXPA03011915A patent/MXPA03011915A/es active IP Right Grant
- 2002-06-21 ES ES02763208T patent/ES2271323T3/es not_active Expired - Lifetime
- 2002-06-21 AT AT02763208T patent/ATE339411T1/de not_active IP Right Cessation
- 2002-06-21 SI SI200230411T patent/SI1414813T1/sl unknown
- 2002-06-21 WO PCT/US2002/019767 patent/WO2003000676A1/en active IP Right Grant
- 2002-06-21 RU RU2004101409/04A patent/RU2271357C2/ru active
- 2002-06-21 UA UA2004010426A patent/UA78709C2/uk unknown
- 2002-06-21 BR BR0210549-7 patent/BRPI0210549B8/pt not_active IP Right Cessation
- 2002-06-21 PT PT02763208T patent/PT1414813E/pt unknown
- 2002-06-21 EP EP02763208A patent/EP1414813B1/de not_active Expired - Lifetime
- 2002-06-21 AU AU2002327183A patent/AU2002327183B2/en not_active Expired
- 2002-06-21 CN CN028164539A patent/CN1545508B/zh not_active Expired - Lifetime
- 2002-06-21 CA CA2451006A patent/CA2451006C/en not_active Expired - Lifetime
- 2002-06-21 DK DK02763208T patent/DK1414813T3/da active
- 2002-06-21 HU HU0400246A patent/HUP0400246A3/hu unknown
- 2002-06-21 DE DE60214733T patent/DE60214733T8/de active Active
- 2002-06-21 IL IL15947402A patent/IL159474A0/xx active IP Right Grant
- 2002-06-21 KR KR1020037016719A patent/KR100759144B1/ko active IP Right Grant
- 2002-06-21 JP JP2003507080A patent/JP4303585B2/ja not_active Expired - Fee Related
-
2003
- 2003-12-19 NO NO20035721A patent/NO20035721L/no not_active Application Discontinuation
-
2006
- 2006-10-23 CY CY20061101517T patent/CY1106214T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE339411T1 (de) | 1,2,4 trioxolan-antimalariamittel | |
| DE69925256D1 (de) | Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen | |
| CY1117133T1 (el) | Ανθελονοσιακα δισπειρο-1,2,4-τριοξολανιων | |
| NO20031626D0 (no) | Pyridonderivater for behandling av atherosklerose | |
| NO20034523L (no) | Pyrazolderivater for behandling av HIV | |
| MA26836A1 (fr) | Heterocycles azotes bicycliques alkylamino substitues en tant qu'inhibiteurs de kinase de proteine p38. | |
| NO20034931D0 (no) | Substituerte 2-pyridin-cykloheksan-1,4-diaminderivater | |
| NO20040845L (no) | Substituerte indeno[1,2-c]isokinolinderivater og deres anvendelse | |
| DK1421075T3 (da) | Piperidinderivater, der er nyttige som CCR5-antagonister til behandling af HIV | |
| DE69936285D1 (de) | INDOLOi2,1-BöQUINAZOLIN-6,12-DIONE ANTIMALARIA DERIVATE UND METHODEN ZUR BEHANDLUNG VON MALARIA | |
| WO2009091433A3 (en) | Spiro and dispiro 1,2,4-trioxolane antimalarials | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| DK0810220T3 (da) | Arylacrylamidderivater som 5-HT1-agonister eller -antagonister | |
| MX2010004601A (es) | Diespiro-1,2,4-trioxolano antimalarial. | |
| DK1313740T3 (da) | Prodrugs af imidazopyridinderivater | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
| IS6914A (is) | 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum | |
| NZ530587A (en) | Diazacycloalkanes as oxytocin agonists | |
| NO20020017D0 (no) | Taxanderivater og fremgangsmåter ved fremstilling derav | |
| ATE298742T1 (de) | Zykloalkenylsulfonamidderivate | |
| PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central | |
| DK1451177T3 (da) | Substituerede 2-pyrrolidin-2-yl-1H-indol-derivater til behandling af migræne | |
| DE60124732D1 (de) | Gatifloxacin als inhibitor der cytokinproduktion | |
| IL138670A0 (en) | Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1414813 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |